Profile
Mohammad Masjedizadeh worked as Director-Drug Substance & Supply at Roche Pharmaceuticals, Inc. and Roche Palo Alto LLC from 1991 to 2012.
From 2012 to 2017, served as Senior Director-Technical Operations at Principia Biopharma, Inc. Also held the position of Chief Technical Officer & Executive VP at Protagonist Therapeutics, Inc. Education includes a doctorate from the University of California, Santa Barbara.
Former positions of Mohammad Masjedizadeh
| Companies | Position | End |
|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 31/12/2016 |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 31/12/2011 |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Discovers and develops medicines | Corporate Officer/Principal | 31/12/2011 |
| PROTAGONIST THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Mohammad Masjedizadeh
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Principia Biopharma, Inc.
Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Discovers and develops medicines | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
- Stock Market
- Insiders
- Mohammad Masjedizadeh
















